1. Home
  2. ADAP vs REE Comparison

ADAP vs REE Comparison

Compare ADAP & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • REE
  • Stock Information
  • Founded
  • ADAP 2008
  • REE 2011
  • Country
  • ADAP United Kingdom
  • REE Israel
  • Employees
  • ADAP N/A
  • REE N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • REE Auto Manufacturing
  • Sector
  • ADAP Health Care
  • REE Consumer Discretionary
  • Exchange
  • ADAP Nasdaq
  • REE Nasdaq
  • Market Cap
  • ADAP 21.3M
  • REE 18.5M
  • IPO Year
  • ADAP 2015
  • REE N/A
  • Fundamental
  • Price
  • ADAP $0.07
  • REE $0.72
  • Analyst Decision
  • ADAP Hold
  • REE Strong Buy
  • Analyst Count
  • ADAP 6
  • REE 2
  • Target Price
  • ADAP $1.02
  • REE $11.75
  • AVG Volume (30 Days)
  • ADAP 63.5M
  • REE 66.5K
  • Earning Date
  • ADAP 11-12-2025
  • REE 09-16-2025
  • Dividend Yield
  • ADAP N/A
  • REE N/A
  • EPS Growth
  • ADAP N/A
  • REE N/A
  • EPS
  • ADAP N/A
  • REE N/A
  • Revenue
  • ADAP $65,084,999.00
  • REE $183,000.00
  • Revenue This Year
  • ADAP N/A
  • REE $6,661.20
  • Revenue Next Year
  • ADAP $52.35
  • REE $2,240.01
  • P/E Ratio
  • ADAP N/A
  • REE N/A
  • Revenue Growth
  • ADAP N/A
  • REE N/A
  • 52 Week Low
  • ADAP $0.04
  • REE $0.53
  • 52 Week High
  • ADAP $1.12
  • REE $11.72
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 44.99
  • REE 53.85
  • Support Level
  • ADAP $0.06
  • REE $0.65
  • Resistance Level
  • ADAP $0.07
  • REE $0.75
  • Average True Range (ATR)
  • ADAP 0.01
  • REE 0.04
  • MACD
  • ADAP 0.01
  • REE 0.01
  • Stochastic Oscillator
  • ADAP 88.67
  • REE 61.33

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About REE REE Automotive Ltd.

REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.

Share on Social Networks: